Heterogeneous interaction of interferon-beta and taxol in human ovarian cancer cells in vitro
Sen, S.; Zocchetti, A.; Beccaglia, P.; Balconi, G.; Erba, E.; D'Incalci, M.
European Journal of Cancer 30a(6): 892-893
1994
ISSN/ISBN: 0959-8049 PMID: 7917558 Document Number: 435381
Document emailed within 1 workday
Related Documents
Frankel, A.; Buckman, R.; Kerbel, R.S. 1997: Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids Cancer Research 57(12): 2388-2393Hamblin, M.R.; Miller, J.L.; Hasan, T. 1996: Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells Cancer Research 56(22): 5205-5210
Nagao, S.; Nakano, A.; Moritake, K.; Morikawa, S.; Harada, T. 1997: Synergistic antitumor effects of human interferon-beta and interferon-gamma on human gastric adenocarcinoma cells Human Cell 10(1): 95-104
Shimada, Y.; Shimoyama, M. 1984: Growth-inhibitory activity of human recombinant beta-interferon (GKT-beta) in vitro Gan 75(12): 1116-1124
Bilir, A.; Altinoz, M.A.; Attar, E.; Erkan, M.; Aydiner, A. 2002: Acetaminophen modulations of chemotherapy efficacy in MDAH 2774 human endometrioid ovarian cancer cells in vitro Neoplasma 49(1): 38-42
Lee, J.; Wang, A.; Hu, Q.; Lu, S.; Dong, Z. 2006: Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice International Journal of Oncology 29(6): 1405-1412
Köpf, J.; Hanson, C.; Delle, U.; Weimarck, A.; Stierner, U. 1996: Action of interferon alpha and beta on four human melanoma cell lines in vitro Anticancer Research 16(2): 791-798
Kmietowicz, Z. 2000: NICE approves Taxol for ovarian cancer Bmj 320(7245): 1293
1996: Chemotherapy of ovarian and breast cancer with Taxol Deutsche Medizinische Wochenschrift 121(50 Suppl): 1-12
Maca, R.D.; Fry, G.L.; Hakes, A.D. 1978: Effects of glucocorticoids on the interaction of lymphoblastoid cells with human endothelial cells in vitro Cancer Research 38(8): 2224-2228
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Chen, G.; Teicher, B.A.; Frei, E. 1996: Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells Anticancer Research 16(6b): 3499-3505
1992: Taxol improves outlook for lung, breast, and ovarian cancer Oncology 6(8): 16
Kemp, K.; Hviid, L.; Kharazmi, A.; Kemp, M. 1997: Interferon-gamma production by human T cells and natural killer cells in vitro in response to antigens from the two intracellular pathogens Mycobacterium tuberculosis and Leishmania major Scandinavian Journal of Immunology 46(5): 495-499
Yang, S.C.; Hsia, S. 1973: Interferon production of human leukemic cells--an in-vitro assay Journal of the Formosan Medical Association 72(11): 612-618
Kim, I.Y.; Ahn, H.J.; Zelner, D.J.; Shaw, J.W.; Sensibar, J.A.; Kim, J.H.; Kato, M.; Lee, C. 1996: Genetic change in transforming growth factor beta (TGF-beta) receptor type i gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells Cancer Research 56(1): 44-48
Passwell, J.H.; Shor, R.; Shoham, J. 1986: The enhancing effect of interferon-beta and -gamma on the killing of Leishmania tropica major in human mononuclear phagocytes in vitro Journal of Immunology 136(8): 3062-3066
Ozols, R.F. 2000: Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer Seminars in Oncology 27(3 Suppl 7: 3-7
Ito, M.; Buffett, R.F. 1981: Cytocidal effect of purified human fibroblast interferon on tumor cells in vitro Journal of the National Cancer Institute 66(5): 819-825
Ezcurdia, L.; Jovtis, S.L.; Mickiewicz, E.; Temperley, G.; Rondinón, M.; Blajman, C.; Cóppola, F.S.; Lewi, D.; Cazap, E.; Breier, S.; Fasce, H.; Fein, L.; Polera, J.; Triguboff, E.; Uranga, G.; Pasccón, G.; Luchina, A.M.; Martínez, C.A.; Politi, P.M.; Rubio, G.; Alvarez, A.M. 1997: Paclitaxel in platinum-resistant ovarian cancer patients. Argentine Multicenter Taxol Group Seminars in Oncology 24(5 Suppl. 15): S15